Literature DB >> 10908722

Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner.

F Shua1, H Kobayashia, K Fukudomeb, N Tsuneyoshib, M Kimotob, T Teraoa.   

Abstract

The new functional role of activated protein C (APC) in the regulation of tissue factor (TF) expression was investigated using the cultured human monoblastic leukemia U937 cell line. A flow cytofluorometric analysis demonstrated that treatment with APC resulted in time- and dose-dependent decrease in TF expression in unstimulated and phorbol ester-stimulated cells. The effect was antagonized by the monoclonal antibody (mAb) to endothelial protein C/APC receptor (EPCR), 252, which strongly inhibited the interaction between APC and EPCR. In contrast, mAbs 49 and 379, which bind to EPCR without blocking APC binding, had no or only a modest effect. It is concluded that culturing U937 cells in the presence of APC caused down-regulation of TF expression through the EPCR-dependent mechanism, independent of whether induction was triggered by phorbol ester.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908722     DOI: 10.1016/s0014-5793(00)01740-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  The role of carrier number on the procoagulant activity of tissue factor in blood and plasma.

Authors:  G W Tormoen; S Rugonyi; A Gruber; O J T McCarty
Journal:  Phys Biol       Date:  2011-11-02       Impact factor: 2.583

2.  Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.

Authors:  Leah M Alabanza; Naomi L Esmon; Charles T Esmon; Margaret S Bynoe
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.

Authors:  Laurent O Mosnier; John H Griffin
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

Review 4.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

5.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

Authors:  Tom van der Poll; Marcel Levi; Jerry A Nick; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

Review 6.  The wnt pathway: a macrophage effector molecule that triggers inflammation.

Authors:  Claudia P Pereira; Esther B Bachli; Gabriele Schoedon
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

7.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells.

Authors:  Xia V Yang; Yajnavalka Banerjee; José A Fernández; Hiroshi Deguchi; Xiao Xu; Laurent O Mosnier; Rolf T Urbanus; Phillip G de Groot; Tara C White-Adams; Owen J T McCarty; John H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

8.  Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Elwira Matuszewska; Stanislaw Sulkowski; Lech Zimnoch; Barbara Politynska; Anna M Wojtukiewicz; Stephanie C Tucker; Kenneth V Honn
Journal:  Biomolecules       Date:  2021-04-29

Review 9.  The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness.

Authors:  C T Esmon
Journal:  Crit Care       Date:  2001       Impact factor: 9.097

10.  Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.

Authors:  Elodie Ducros; Shah Soltan Mirshahi; Anne-Marie Faussat; Pezhman Mirshahi; Sophie Dimicoli; Ruoping Tang; Julia Pardo; Jdid Ibrahim; Jean-Pierre Marie; Amu Therwath; Jeannette Soria; Massoud Mirshahi
Journal:  Cancer Med       Date:  2012-07-23       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.